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Comment on Breunis et al, page 1029

The
yin and yang of Fc␥ receptors in ITP
---------------------------------------------------------------------------------------------------------------Steven E. McKenzie

CARDEZA FOUNDATION FOR HEMATOLOGICAL RESEARCH, THOMAS JEFFERSON

UNIVERSITY

In this issue of Blood, Breunis and colleagues examine the role of genetic variation
in the human Fc receptors for IgG in the susceptibility to idiopathic thrombocytopenic purpura (ITP).
been the appreciation that the activating Fc␥
receptors, encoded by FCGR2A, -2C, -3A,
and -3B, compete with the inhibitory Fc␥ receptor, encoded by FCGR2B, to determine
cellular responses to immune complexes and
antibody-coated cells.
The work by this team, led by Dr Taco
Kuijpers, is noteworthy for several reasons.
First, the authors have achieved a technical
tour-de-force, developing
multiplex ligationdependent polymerase
amplification assays (MLPAs) to simultaneously
identify both single nucleotide polymorphisms
(SNPs) and copy number
variations (CNVs) in the 5
gene locus containing the
so-called low-affinity Fc
receptors for IgG:
FCGR2A, -2B, -2C, -3A,
and -3B. These genes are
highly homologous, and
genetic studies of this region are notoriously difficult. The authors typed 8
biologically significant
variations at the same time.
The SNP and CNV alleles in the human FCGR2,3 gene locus at chromoSecond, they discovered a
some 1q23 that contribute to susceptibility to autoimmune disease are
new CNV for the
shown schematically, including the genetic variation in FCGR2C in the
FCGR3A gene. Third,
study on ITP by Breunis et al. (The alleles are defined in that article.) The
their assays combined the
balance of activation and inhibition contributes to greater or lesser susability to identify an imceptibility to autoimmune disease.
he Fc␥ receptors contribute to the susceptibility to autoimmune diseases such as
ITP in several ways: (1) they modulate dendritic cell antigen processing and presentation,
(2) they modulate antibody production by
B cells, and (3) they participate in effector cell
functions, such as phagocytosis, antibodydependent cellular cytotoxicity, and mediator
release. The key finding in recent years has
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portant FCGR2C SNP (ORF, open reading
frame, versus STP, stop codon) with the ability to detect deletion or duplication of a block
containing the adjacent FCGR2C and
FCGR3B genes. Finally, in a study comparing
the frequency of these FCGR2,3 gene variations in healthy individuals versus in children
and adults with ITP, analyzed separately and
as a group, they discovered a significant overrepresentation of the FCGR2C ORF allele in
individuals with ITP. The team convincingly
confirmed the work by Ernst, Herberman, and
colleagues1 that the FCGR2C genotype determines the phenotype, with respect to protein
expression and function. Since FCGR2C is an
activating receptor in monocytes/macrophages and natural killer (NK) cells, the findings are consistent with the current paradigm
in the field that the balance of activating versus
inhibitory Fc␥ receptors contributes to susceptibility to autoimmune disease (see figure).
Where does the field go from here? These
8 genetic variations are not in linkage disequilibrium, but individuals will be endowed in
this region of chromosome 1q23 with a haplotype of FCGR2,3 SNPs and CNV that can
influence the susceptibility to ITP and other
auto- or allo-immune disorders. In the figure,
the hypothesized set of alleles conferring
greater susceptibility is contrasted to the set
conferring lesser susceptibility. Further technical advances and larger numbers of patients
and controls, especially those of diverse ethnic
groups, will be needed to test the potential
clinical value of assaying genetic differences in
susceptibility. Equally exciting, however, is
the prospect that these genetic variations contribute to differences in the response to therapeutics for ITP. Modulation of Fc␥ receptor
activating and inhibitory functions are mainstays of ITP treatment.2-4 We may even go so
far as to link responses to a broader set of antibody therapeutics for human disease to the
haplotype of FCGR2,3 genetic variations.
Conflict-of-interest disclosure: The author
declares no competing financial interests. ■
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Comment on Shida et al, page 1295

Shear elegance: regulation of thrombus
growth
by shear stress
---------------------------------------------------------------------------------------------------------------William E. Hobbs II and José A. López

PUGET SOUND BLOOD CENTER

A new study by Shida et al provides an elegant explanation for how vessel wall injuries are repaired without occluding the vessel.
he hemostatic repair of damaged endovasculature resembles an intricate symphony orchestrated by platelets and a variety of plasma
proteins, all tightly regulated to prevent lumen
occlusion and thromboembolism. One key
player in this symphony, von Willebrand factor
(VWF), functions to bridge exposed collagen on
damaged subendothelial surfaces to receptors on
circulating platelets and to bridge platelets to
each other as the thrombus grows.1 Its ability to
perform both tasks relates to the size of its multimers and exposure to shear stress.
VWF is synthesized in only 2 cell types, endothelial cells and megakaryocytes, and is released constitutively by endothelial cells or from
storage granules of endothelial cells or platelets
in response to secretagogues. The VWF newly
released from granules is enormous (hence the
designation ultra-large VWF or ULVWF) and
hyperadhesive.2 ADAMTS13 rapidly converts
ULVWF to smaller and less adhesive species
through proteolytic cleavage at the peptide bond
Y1605-M1606 within the A2 domain. Proteolysis is enhanced by shear stress3 and by platelet
binding.4 Shear stress is also one of the variables
that enhances the binding of plasma VWF to
platelets.5 In this issue of Blood, Shida and colleagues provide a fascinating explanation for how
shear stress can facilitate platelet thrombus formation while simultaneously limiting thrombus
growth. In a simple and elegant experiment, the
investigators examined the contribution of
ADAMTS13 activity to the growth of platelet
thrombi at different shear stresses. They perfused blood over a collagen-coated surface in a
perfusion chamber and used 2 very valuable
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monoclonal antibodies to probe ADAMTS13
functions: one that blocked ADAMTS13 activity and one that bound only after ADAMTS13
cleaved VWF (N10). As expected, ADAMTS13
blockade increased thrombus growth rate and
volume concurrent with decreased N10 antibody
binding. When ADAMTS13 was unopposed,
N10 binding increased, indicating increased
VWF cleavage in the smaller thrombi that resulted, a phenomenon that became more pronounced with increased shear stress. N10 staining also increased with increased distance from
the base of the thrombus, being greatest at the
surface. Extrapolated to a high-shear mural
thrombus in vivo, these results suggest that as
shear stress increases by progressive luminal
narrowing, so does cleavage of VWF by
ADAMTS13. Thus, not only does
ADAMTS13 control VWF reactivity by reducing the size and reactivity of its ultra-large forms,

it also acts on the form of VWF normally found in
plasma as it participates in the buildup of thrombi.
These findings suggest a mechanism that
allows repair of vessel wall defects without the
repair process completely occluding the vessel.
They also provide further insight into the
pathophysiology of the most extreme manifestation of ADAMTS13 deficiency: thrombotic
thrombocytopenic purpura (TTP). In TTP,
ADAMTS13 deficiency may have 2 important
but distinct roles: first, it allows ULVWF to
linger on the vessel wall and bind the first layer
of platelets; and second, it is unable to prevent
platelets that attach to the thrombus subsequently from completely occluding the vessel.
This elegant study also demonstrates that
experiments need not be particularly complicated in nature or technologically difficult to
provide mechanistic insights; they just have to
be carefully considered.
Conflict-of-interest disclosure: The authors
declare no competing financial interests. ■
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Comment on Syrjala et al, page 989

Sexuality
in long-term survivors
---------------------------------------------------------------------------------------------------------------Gerard Socié

HOSPITAL SAINT LOUIS

In this issue of Blood, Syrjala and coworkers highlight that sexual recovery in longterm survivors after allogeneic stem-cell transplantation may well be the most frequent late effect ever reported.
he number of long-term survivors of hematopoietic cell transplantation (HCT) is
increasing rapidly; worldwide, more than
45 000 patients receive HCT each year. Pa-
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tients with leukemias who survive without
recurrent malignancy for 2 years after allogeneic HCT currently have an 89% probability
of surviving for 5 or more years. Research on
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